Table 4.
Distribution of FVL genotype in European American and African American patients with arterial and venous thromboembolic events.
| Race | Genotype | Site of Thromboembolism* | |||||
|---|---|---|---|---|---|---|---|
| None (n=68)
|
Arterial (n=111)
|
Venous (n= 89)
|
|||||
| n | % | n | % | n | % | ||
| African American | GA | 0 | 0.0 | 1 | 1.8 | 1 | 2.0 |
| GG | 31 | 100.0 | 54 | 98.2 | 49 | 98.0 | |
| European American | GA | 0 | 0.0 | 5 | 8.9 | 6 | 18.2 |
| GG | 37 | 100.0 | 51 | 91.1 | 27 | 81.8 | |
|
| |||||||
| p-value | - | 0.206 | 0.014 | ||||
No participant was homozygous for the ‘AA’ genotype
*
Arterial thromboembolism includes patients with MI, Stroke & TIA. Venous thromboembolism includes patients with DVT & PE. ‘None’ denotes patients with no thromboembolic event. 26 patients (13 African Americans) had both arterial and venous events.
Significant p-values bolded